Is PRP worth it? It depends entirely on your condition. For knee arthritis, tennis or golfer's elbow, and chronic plantar fasciitis, the research is genuinely strong and PRP is often worth every dollar. For the Achilles, high-quality trials show no benefit at all. The honest answer isn't "yes" or "no", it's "for what, and for whom."
Platelet-rich plasma gets marketed as a cure-all, and that's exactly the problem. It isn't. But for the right injury in the right candidate, it's one of the most useful non-surgical tools in orthopedics. The only way to answer "is it worth it?" is to look at the evidence one condition at a time, which is what the rest of this article does, with the studies named and the weak spots left in.
Where the evidence is strong
Knee osteoarthritis, worth it for the right knee
Knee arthritis is where PRP's evidence is strongest. Multiple 2024–2025 systematic reviews and meta-analyses found that PRP reduces pain and improves function out to 12 months and outperforms hyaluronic-acid (gel) injections, with roughly double the odds of a good outcome (odds ratio ≈ 2.19). One analysis found that about 59% of patients with moderate, KL-grade-3 arthritis did well when treated with three or more injections.
The honest caveat: the American Academy of Orthopaedic Surgeons (AAOS, 2021) still rates PRP only a "limited" recommendation, largely because preparation methods vary widely between clinics. That's a fair criticism, and it's exactly why an ultrasound-guided, surgeon-performed protocol matters. PRP works best before a knee is fully bone-on-bone; it won't regrow an end-stage joint. See the full knee evidence breakdown.
Tennis & golfer's elbow, among the best-supported uses
Chronic elbow tendinopathy is a standout. In randomized controlled trials, cortisone works faster but fades and can weaken the tendon over time, while PRP keeps improving. Head-to-head, roughly 73% of PRP patients succeed long-term versus about 49% with corticosteroid on pain scores, with similar margins for function (DASH). A 2024 meta-analysis of 26 trials summarized it cleanly: cortisone wins early, PRP wins long-term. More on PRP for tennis and golfer's elbow.
Plantar fasciitis, better than cortisone past six months
For stubborn, chronic heel pain, PRP is a strong option. 2024–2025 meta-analyses (including one pooling 24 randomized trials) found PRP matches cortisone in the first month but delivers superior, longer-lasting relief from roughly six to twelve months, because it targets the tissue rather than just quieting inflammation. Read the plantar fasciitis evidence.
Where the evidence is mixed
Rotator cuff & shoulder, helps irritated tendons, not full tears
A 2024 meta-analysis of about 30 randomized trials found PRP reduces shoulder pain in the short and medium term versus placebo or cortisone, but improvements in strength and function are inconsistent, and there's no professional consensus for routine use. The benefit appears limited to tendinopathy with an intact tendon. PRP is not a reliable substitute for surgically repairing a significant full-thickness tear. See the shoulder breakdown.
Hip osteoarthritis, modest, not first-line
For the hip, PRP can reduce pain with a strong safety profile, but a 2024 systematic review found it was not significantly better than hyaluronic-acid injections, so it isn't considered a first-line treatment. It may be worth a try for selected, well-informed patients with moderate arthritis who want a regenerative option before surgery, with realistic expectations. More on PRP for the hip.
Where the evidence is weak, and we'll say so
Achilles tendinopathy, not worth it, honestly
This is the one we're most candid about. A 2024 meta-analysis of randomized trials found no significant difference between PRP and placebo for Achilles tendinopathy on the standard VISA-A function score at 3, 6, and 12 months. Some patients feel a brief flicker of improvement, but it isn't sustained.
For the Achilles specifically, the data simply isn't there. Progressive (eccentric) loading rehab has the best evidence, with surgery reserved for specific cases. We'd rather tell you that than treat something the research doesn't support.
Read our full, honest take on PRP for the Achilles.
What about cost and value?
Here's the money question answered plainly:
- Cost: PRP typically runs $1,200–$3,000 cash, depending on the area treated and the number of sessions.
- Insurance: Most insurers classify PRP as investigational and don't cover it. HSA and FSA funds are generally eligible, and we provide detailed receipts.
- Recovery: Expect soreness for a few days, then gradual improvement over 4–12 weeks as the tissue heals, no hospital stay, no months off your feet.
- Odds of improvement: Around 80–90% of appropriate candidates see meaningful improvement. The key word is appropriate, matching the treatment to a condition the evidence supports.
Put that next to the alternatives. Surgery can run $15,000–$50,000 with months of recovery; repeated cortisone shots are cheap but can weaken tissue and rarely last beyond a few weeks. For the right condition, PRP often sits in the value sweet spot. See our full pricing and HSA/FSA details.
So, is PRP worth it?
PRP is "worth it" when it's matched to the right condition and the right candidate. For knee arthritis that isn't yet bone-on-bone, a chronic tennis elbow, or heel pain that cortisone only quiets for a few weeks, the evidence says yes. For an Achilles problem, the evidence says no, and a good surgeon will tell you that before you spend a dollar.
That's the real test of whether PRP is worth it: not the treatment itself, but whether the person offering it will tell you when it isn't. The honest answer to "should I get PRP?" starts with an honest assessment. Find out in two minutes whether you're a candidate.
Medically reviewed
Reviewed by Dr. David Hock, DO, Board-Certified Orthopedic Surgeon, affiliated with Hilo Medical Center. Published December 20, 2025 · Last reviewed June 15, 2026. This article is for education and is not a substitute for an individual medical evaluation.
Frequently asked questions
Is PRP therapy worth the money?
It depends entirely on your condition. PRP is well worth it for knee osteoarthritis, tennis or golfer's elbow, and chronic plantar fasciitis, where studies show it outperforms standard injections. It is not worth it for Achilles tendinopathy, where high-quality trials show no benefit over placebo. About 80–90% of properly selected candidates improve.
What is the success rate of PRP?
Success depends on the target. For tennis elbow, randomized trials show roughly 73% long-term success versus about 49% for cortisone. For moderate (KL-3) knee arthritis, about 59% of patients do well with three or more injections. For the Achilles, the success rate is no better than placebo.
Does insurance cover PRP, and how much does it cost?
Most insurers classify PRP as investigational and don't cover it. Cash prices typically run $1,200–$3,000 depending on the area and number of sessions, but HSA and FSA funds are generally eligible. Island Orthobiologics publishes pricing openly and provides detailed receipts.